2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 2.769.397 | 4.640.699 | 5.318.292 | 5.930.551 | 5.774.153 | 6.719.731 | 8.094.627 | 10.101.120 | 11.651.416 | 10.464.774 |
Total Income - EUR | 2.781.029 | 4.776.397 | 5.404.172 | 6.030.248 | 5.895.464 | 6.800.191 | 8.253.558 | 10.253.594 | 11.558.112 | 10.641.369 |
Total Expenses - EUR | 2.767.894 | 3.676.398 | 4.631.913 | 5.580.127 | 5.537.233 | 6.372.662 | 7.831.928 | 9.771.240 | 11.053.369 | 10.068.277 |
Gross Profit/Loss - EUR | 13.135 | 1.100.000 | 772.260 | 450.120 | 358.230 | 427.529 | 421.630 | 482.354 | 504.743 | 573.092 |
Net Profit/Loss - EUR | 13.135 | 1.086.241 | 646.601 | 375.457 | 298.326 | 350.935 | 353.321 | 410.767 | 429.631 | 487.546 |
Employees | 86 | 75 | 90 | 109 | 114 | 113 | 128 | 157 | 117 | 125 |
Check the financial reports for the company - Jabs Glodeni S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 4.156.375 | 3.889.590 | 3.513.537 | 3.186.271 | 2.886.209 | 2.715.677 | 2.595.028 | 2.484.000 | 2.551.386 | 2.686.702 |
Current Assets | 441.276 | 1.920.941 | 2.930.801 | 1.444.687 | 1.945.731 | 2.659.715 | 3.036.362 | 3.521.190 | 3.786.540 | 4.680.612 |
Inventories | 340.989 | 669.277 | 687.899 | 675.191 | 793.030 | 672.028 | 972.589 | 1.225.238 | 1.327.520 | 1.259.403 |
Receivables | 54.072 | 1.188.410 | 2.171.092 | 510.186 | 1.034.305 | 1.589.615 | 581.658 | 922.063 | 1.127.499 | 735.890 |
Cash | 46.215 | 63.254 | 71.810 | 259.310 | 118.396 | 398.071 | 1.482.115 | 1.373.889 | 1.331.521 | 2.685.319 |
Shareholders Funds | 4.522.748 | 5.730.552 | 6.318.709 | 4.460.168 | 4.676.643 | 4.937.010 | 5.196.736 | 5.505.266 | 5.951.977 | 6.421.474 |
Social Capital | 133.163 | 134.274 | 132.905 | 130.656 | 128.258 | 125.774 | 123.390 | 120.654 | 121.028 | 120.661 |
Debts | 75.037 | 85.477 | 127.300 | 170.963 | 158.860 | 435.584 | 437.559 | 513.567 | 395.392 | 921.134 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "1625 - 1625" | |||||||||
CAEN Financial Year |
1623
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Jabs Glodeni S.r.l.